Clinical benefit from palbociclib, letrozole and goserelin combination therapy for sweat gland carcinoma with neuroendocrine differentiation (SCAND)

Affiliations

• ¹ Department of Dermatology, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France.
• ² Department of Tumor Genomics and Pharmacology, Saint-Louis University Hospital, AP-HP, Paris-Cité University, Paris, France.
• ³ INSERM, UMR-S 976, Paris, France.
• ⁴ Department of Medical Oncology, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France.
• ⁵ Department of Pathology, Avicenne University Hospital, AP-HP, Sorbonne-Paris-Nord University, Bobigny, France.
• ⁶ IRHE, Bobigny, France.
• ⁷ Department of Dermatology, Delafontaine Hospital, Saint-Denis, France.
• ⁸ Department of Pathology, Saint-Louis University Hospital, AP-HP, Paris-Cité University, Paris, France.
• ⁹ INSERM UMR1124, Campus Saint-Germain-Des-Prés, Université Paris Cité, Paris, France.